World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
51
Citations
12438
World Ranking
5161
National Ranking
2841

Joy M. Schmitz publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Joy M. Schmitz sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 205 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Joy M. Schmitz D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Joy M. Schmitz sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 51 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Joy M. Schmitz is affiliated with The University of Texas Health Science Center at Houston in the United States. Their work spans multiple fields of study including Medicine, Psychology, and Neuroscience, with publication counts of 110, 49, and 47 respectively. Within these broad areas, Schmitz's research often focuses on subfields such as Epidemiology, Clinical Psychology, Cognitive Neuroscience, Cellular and Molecular Neuroscience, and Pharmacology.

The scientist has contributed extensively to research on topics that cover Neurotransmitter Receptor Influence on Behavior, Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment, Cannabis and Cannabinoid Research, Posttraumatic Stress Disorder Research, Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes, and HIV, Drug Use, Sexual Risk.

Joy M. Schmitz has coauthored many publications with several frequent collaborators, including:

  • Scott D. Lane
  • Robert Suchting
  • Heather E. Webber
  • Constanza de Dios
  • Jin H. Yoon

The researcher's work is published in numerous academic venues. The most frequent include:

  • Drug and Alcohol Dependence
  • Experimental and Clinical Psychopharmacology
  • Journal of Addiction Medicine
  • Biological Psychiatry
  • Nicotine & Tobacco Research

Among recent papers authored or coauthored by Schmitz are:

  • "Bupropion and Naltrexone in Methamphetamine Use Disorder" (2021), published in New England Journal of Medicine
  • "Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial" (2021), published in Nicotine & Tobacco Research
  • "A meta-analysis of tract-based spatial statistics studies examining white matter integrity in cocaine use disorder" (2020), published in Addiction Biology
  • "Elevated Neutrophil to Lymphocyte Ratio in Older Adults with Cocaine Use Disorder as a Marker of Chronic Inflammation" (2020), published in Clinical Psychopharmacology and Neuroscience
  • "White matter deficits in cocaine use disorder: convergent evidence from in vivo diffusion tensor imaging and ex vivo proteomic analysis" (2021), published in Translational Psychiatry

Best Publications

  • Psychiatric aspects of impulsivity

    F. Gerard Moeller;Ernest S. Barratt;Donald M. Dougherty;Joy M. Schmitz

  • The impact of impulsivity on cocaine use and retention in treatment

    F.Gerard Moeller;Donald M. Dougherty;Ernest S. Barratt;Joy M. Schmitz

  • Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty Acids

    G J Dehmer;J J Popma;E K van den Berg;E J Eichhorn

  • Dextroamphetamine for cocaine-dependence treatment : A double-blind randomized clinical trial

    John Grabowski;Howard Rhoades;Joy Schmitz;Angela Stotts

  • Motivational interviewing with cocaine-dependent patients: A pilot study.

    Angela L. Stotts;Joy M. Schmitz;Howard M. Rhoades;John Grabowski

  • Replacement medication for cocaine dependence: methylphenidate.

    John Grabowski;John D. Roache;Joy M. Schmitz;Howard Rhoades

  • Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.

    John Grabowski;Howard Rhoades;Angela L Stotts;Katherine Cowan

  • Bupropion and Naltrexone in Methamphetamine Use Disorder

    Madhukar H Trivedi;Robrina Walker;Walter Ling;Adriane Dela Cruz

  • Fluoxetine Is Ineffective for Treatment of Cocaine Dependence or Concurrent Opiate and Cocaine Dependence: Two Placebo-controlled, Double-blind Trials

    John Grabowski;Howard Rhoades;Ronith Elk;Joy Schmitz

  • Retention, HIV risk, and illicit drug use during treatment: Methadone dose and visit frequency

    Howard M. Rhoades;Dan Creson;Ronith Elk;Joy Schmitz

  • Naltrexone and relapse prevention treatment for cocaine-dependent patients

    Joy M Schmitz;Angela L Stotts;Howard M Rhoades;John Grabowski

  • Relationship between impulsivity and decision making in cocaine dependence

    Kimberly L. Kjome;Scott D. Lane;Joy M. Schmitz;Charles Green

  • Fluoxetine treatment of cocaine-dependent patients with major depressive disorder.

    Joy M Schmitz;Patricia Averill;Angela L Stotts;F.Gerard Moeller

  • Risperidone for the treatment of cocaine dependence: Randomized, double- blind trial

    John Grabowski;Howard Rhoades;Peter Silverman;Joy M. Schmitz

  • Determining predictors of attrition in an outpatient substance abuse program.

    Shelly L. Sayre;Joy M. Schmitz;Angela L. Stotts;Patricia M. Averill

  • Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.

    Marc E. Mooney;David V. Herin;Joy M. Schmitz;Nidal Moukaddam

  • Behavioral and emotional problems among children of cocaine- and opiate-dependent parents.

    Catherine Stanger;Stephen T. Higgins;Warren K. Bickel;Ronith Elk

  • Citalopram combined with behavioral therapy reduces cocaine use: A double-blind, placebo-controlled trial

    F. Gerard Moeller;Joy M. Schmitz;Joel L. Steinberg;Charles M. Green

  • Relationship between attentional bias to cocaine-related stimuli and impulsivity in cocaine-dependent subjects.

    Shijing Liu;Scott D. Lane;Joy M. Schmitz;Andrew J. Waters

  • Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform.

    Joy M. Schmitz;Marc E. Mooney;F. Gerard Moeller;Angela L. Stotts

Frequent Co-Authors

Scott D. Lane
Scott D. Lane The University of Texas Health Science Center at Houston
John Grabowski
John Grabowski University of Minnesota
F. Gerard Moeller
F. Gerard Moeller Virginia Commonwealth University
Howard M. Rhoades
Howard M. Rhoades The University of Texas Health Science Center at Houston
Ponnada A. Narayana
Ponnada A. Narayana The University of Texas Health Science Center at Houston
Joel L. Steinberg
Joel L. Steinberg Virginia Commonwealth University
Alan C. Swann
Alan C. Swann The University of Texas Health Science Center at Houston
Gabriel R. Fries
Gabriel R. Fries The University of Texas Health Science Center at Houston
Thomas R. Kosten
Thomas R. Kosten Baylor College of Medicine
Rodrigo Grassi-Oliveira
Rodrigo Grassi-Oliveira Pontifical Catholic University of Rio Grande do Sul

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a psychology degree in the USA opens doors to a wide array of rewarding career opportunities, including fields like speech-language pathology. For those drawn to helping individuals overcome communication and swallowing disorders, both traditional and online degrees can provide a solid foundation for entering this growing sector.

The pathway to becoming a licensed professional varies by state. For example, becoming a speech therapist in Washington requires a master's degree, completion of clinical experience, and passing a national examination. Meanwhile, the slp requirements in West Virginia emphasize accredited education, supervised practice, and state-specific licensing exams.

Other states have their own unique pathways, such as the slp requirements in Wisconsin, which include professional development and continuing education, or the slp requirements in Wyoming, which highlight background checks and adherence to local regulations.

As you explore online psychology programs, keep in mind the specialized requirements for different states. Researching your state's criteria early will help you chart an efficient course toward your ideal career in psychology or speech-language pathology.

Best Scientists Citing Joy M. Schmitz

Trending Scientists

Recently Published Articles